Zhifang Li

机构：Wuhan University, Zhongnan Hospital of Wuhan University · ORCID：0000-0001-8398-7338

发表论文 125 篇 · 总被引 2324 次 · h-index 27

代表论文

Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis (2024 · Phytomedicine · 被引 39)
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers (2025 · Journal of Medicinal Chemistry · 被引 24)
Gut microbiota metabolite tyramine ameliorates high-fat diet-induced insulin resistance via increased Ca2+ signaling (2024 · The EMBO Journal · 被引 23)
Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse (2024 · Molecular Therapy — Nucleic Acids · 被引 22)
Neutrophil Mobilization Triggers Microglial Functional Change to Exacerbate Cerebral Ischemia‐Reperfusion Injury (2025 · Advanced Science · 被引 18)
Recent advances of lysine lactylation in prokaryotes and eukaryotes (2025 · Frontiers in Molecular Biosciences · 被引 13)